MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2019 International Congress

    Olfactory Hallucinations as a Non-motor sign of Parkinson’s disease- a cross sectional study

    S. Chandra, M. Schiess, R. Mehanna (Houston, TX, USA)

    Objective: To describe the prevalence and characteristics of Olfactory Hallucinations (OlfH) in patients with Parkinson’s Disease (PD) in a tertiary movement clinic. Background: Hallucinations are…
  • 2019 International Congress

    Nonmotor Symptoms in Parkinson’s Disease: 36-month Follow-up Study Comparing Bilateral Subthalamic Stimulation and Standard-of-care Medication

    S. Jost, A. Sauerbier, K. Ray-Chaudhuri, V. Visser-Vandewalle, K. Ashkan, M. Silverdale, J. Evans, A. Rizos, A. Schnitzler, P. Löhrer, JN. Petry-Schmelzer, M. Barbe, A. Antonini, P. Martinez-Martin, G. Fink, L. Timmermann, H. Dafsari (Cologne, Germany)

    Objective: To examine 36-month effects of bilateral subthalamic nucleus (STN) deep brain stimulation (DBS) on nonmotor symptoms (NMS) and self-reported quality of life compared to…
  • 2019 International Congress

    Classify Parkinson’s Disease with Mild Cognitive Impairment: Machine Learning Approach

    SS. Cho, C. Li, Y. Koshimori, J. Kim, L. Christopher, M. Dı´ez-Cirarda, M. Valli, A. Mihaescu, S. Houle, A. Strafella (Toronto, ON, Canada)

    Objective: To determine how multimodal neuroimaging data can contribute to the classification of Parkinson’s disease (PD) patients with mild cognitive impairment (MCI) from PD without…
  • 2019 International Congress

    Aerobic exercise alters brain structure and function in Parkinson’s disease – a randomized controlled trial

    M. Johansson, I. Cameron, N. Vander Kolk, N. de Vries, I. Toni, B. Bloem, R. Helmich (Nijmegen, Netherlands)

    Objective: To test whether aerobic exercise can influence Parkinson’s disease (PD)-related changes in resting-state functional connectivity in motor and non-motor brain networks, as measured with…
  • 2019 International Congress

    Effective deep brain stimulation co-modulate cross-frequency coupling

    S. Groppa, M. Glaser, N. Koirala, M. Bange, M. Muthuraman (Mainz, Germany)

    Objective: The disruption of pathological signals in the cortico-basal ganglia- network has been hypothesized as a mechanism of action of deep brain stimulation (DBS).  However,…
  • 2019 International Congress

    Neurofeedback-guided motor imagery in Parkinson’s disease

    S. Tinaz, M. Elfil, J. Lemere, S. Basu, R. Sinha, D. Scheinost, M. Hampson (New Haven, CT, USA)

    Objective: We tested whether patients with Parkinson’s disease (PD) can increase the functional connectivity (FC) between the right insula (rIns) and dorsomedial frontal cortex (dmFC)…
  • 2019 International Congress

    Art du Deplacement (ADD)/Parkour therapy for people with Parkinson’s disease (PDP)

    M. Schwed, T. Getrost, K. Torchia, G. Yao (Pfungstadt, Germany)

    Objective: The purpose of this study was to transfer ADD training methods into safe training paradigms for PDP, and psychologically framed coping strategies for mood…
  • 2019 International Congress

    The Clinical Features of Parkinson’s Disease with 20 Years or More Survival

    JJ. Lin, KC. Yueh (Nantou, Taiwan)

    Objective: To evaluate the clinical demographic data in Parkinson’s disease (PD) survivors with 20 years duration and beyond (PD-20) and investigate the impact of age…
  • 2019 International Congress

    Analysis of Levodopa Content in Commercial Formulations of Mucuna pruriens Seeds Used in Integrative Treatment of Parkinson’s Disease

    T. Denne (Kenmore, WA, USA)

    Objective: Objective: Formulations of Mucuna pruriens (MP) seed products are readily available through the internet and health food stores, and are used by some Parkinson's…
  • 2019 International Congress

    Oligomeric Alpha-synuclein in Erythrocyte Membrane in Early Parkinson’s Disease

    GL. Liu, C. Tian, T. Feng (Beijing, China)

    Objective: To determine whether α-synuclein concentrations in the cell membrane and cytoplasm of erythrocytes are altered in PD patients and to evaluate their potential role…
  • « Previous Page
  • 1
  • …
  • 149
  • 150
  • 151
  • 152
  • 153
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley